Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


 

Contact Us

202-789-2300
info@allhealth.org

1444 Eye Street, NW, Ste. 910
Washington, DC 20005-6573


Sen. Roy Blunt
Honorary Co-Chairman

Sen. Ben Cardin
Honorary Co-Chairman


Dr. Bob Graham
Chairman

In The Spotlight

Post-Election Symposium: Health Care Policy in 2017

Briefing Wednesday, November 16, 2016

This post-election, half-day symposium previewed critical 2017 health care policy issues. Our panelists reviewed what we can learn from the election results and public opinion, what priorities we can expect for the new Trump administration, and what health care issues will be on the agenda for the new Congress. Read More

Recent Briefings

While recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, and preventing disease, stakeholders throughout the health care system have serious concerns about prescription drug affordability. Payment methods that incorporate concepts of value and patient-centered care are among the emerging policy options to address the cost of drugs for Medicare patients. This briefing featured presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists discussed an array of policy options to align drug prices with value through alternative payment models.  Read More

The enactment of the Veterans Choice Act in 2014 renewed discussions about the capacity of the VA health care system to meet the needs of our nation's veterans. In addition to tackling issues related to access to VA-owned facilities, the Veterans Choice Act prompted a thorough examination of the quality of care provided to veterans in the VA system, the VA's ability to purchase care from the private sector, and the VA's capacity to provide services. This briefing provided an introduction to the VA health system, presented an overview of how the VA acts as both provider and purchaser of care, and discussed policy prospects for the future. Read More

The Affordable Care Act's health insurance marketplaces rely on robust competition to control costs and to provide consumer choice. But the decisions of several large insurers to scale back their 2017 marketplace participation, and the failure of many health insurance co-ops will leave marketplace shoppers in many states with fewer choices than they had in 2016. Furthermore, those insurers remaining in the exchanges have often found their marketplace customers to be less healthy than they projected, and they are raising premiums in response. Our briefing focuses on these trends, what they mean for the long-term viability of the marketplaces, and what public policy steps can be taken to bring more healthy people into the risk pool and to encourage insurer participation in the individual market. Read More


Medicare & Prescription Drug Prices

Get Alliance Updates

Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


Webcast: The Emerging Biosimilars Market


Watch the webcast of our June 20 panel discussion on biosimilar biological medications.

Read More

Copyright 1997-2016 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      info@allhealth.org      Sitemap